The TRACER model, a Transformer with Contrastive Event Representation designed to predict timelines leading to rare hospitalization events in low-resolution and irregularly sampled telemonitoring data, shows promise in identifying signs of clinical deterioration that allow for alerts to be generated to provide counteractive treatment in patients with HF.
Abstract
Objective: Heart failure (HF) presents a healthcare challenge due to its high comorbidity burden, aging patient population and frequent hospitalizations. Remote monitoring offers a promising approach to managing HF patients by early detection of health deterioration. Developing autonomous systems to detect signs of worsening in telemonitoring data is of interest to reduce the workload of healthcare personnel. Methods: We propose the TRACER model, a Transformer with Contrastive Event Representation, designed to predict timelines leading to rare hospitalization events in low-resolution and irregularly sampled telemonitoring data. TRACER incorporates time-aware embeddings for each biomarker, contrastive pre-training to enhance anomaly detection via representation learning, and independent binary classifiers for detection. We used measurement data containing remotely recorded biomarker sequences from 276 HF patients segmented into overlapping windows based on temporal rules, and labeled the windows based on the occurrence of HF relevant hospitalizations at the latter edge of the window. Results: TRACER was able to correctly predict 66.7% timelines leading up to HF hospitalizations in the highly imbalanced real-world dataset with an overestimation of 7.9%. Reformulating the training of TRACER as an event detection problem improved the predictive performance compared with training directly on forecasting windows, enabling more effective use of the limited hospitalization events. Conclusion: TRACER demonstrated superior performance in detecting signs of worsening status in real-world telemonitoring data compared to the other tested models. Significance: TRACER shows promise in identifying signs of clinical deterioration that allow for alerts to be generated to provide counteractive treatment in patients with HF.
Traditional ML can outperform DL models such as Transformers on tabular-dominated, multimodal clinical prediction tasks while preserving interpretability, underscoring decision-support systems’ potential to aid timely diagnosis.
Alban Lutz, Fabio Hellmann, E. André· medRxiv· 0 citations
BACKGROUND
Artificial intelligence (AI)-enabled wearable monitoring can detect individualized physiological deviations preceding heart failure (HF) decompensation, but whether these signals can be translated into improved outcomes remains uncertain.
OBJECTIVES
This study aims to evaluate the feasibility of integratin...
Konstantinos Sideris, Carsten Schmalfuss, Neil Lewis et al.· JACC. Heart failure· 0 citations
Introduction Cardiovascular diseases (CVD) are a leading global health challenge, particularly in resource-constrained settings where delayed diagnosis worsens outcomes. Abnormal heart rate (tachycardia/bradycardia) is a modifiable, independent risk factor that benefits from early, automated detection. Methods We used...
J. Ferreira, L. Elvas· Frontiers in Artificial Inte...· 0 citations
Background/Objectives: Hemodialysis is a treatment for patients with kidney disease, yet it remains risk-prone due to potential technical or physiological instabilities. Dialysis machines rely on reactive safety mechanisms that trigger alarms only when predefined thresholds are reached. This often alerts clinical staff...
A. Nicosia, N. Cancilla, Marco Siino et al.· Diagnostics· 0 citations
Heart failure is a major cardiovascular condition in which clinical status may change over time and may require timely reassessment. Artificial intelligence (AI) has been investigated for diagnosis, prognosis, risk stratification, and prediction of outcomes in heart failure, but predictive performance alone does not es...
Harsh Panchal· Journal of Cardiology and He...· 0 citations
Cardiovascular disease (CVD) remains the leading cause of death worldwide, and early risk identification outside the clinic remains difficult because conventional diagnostic pathways rely on episodic clinical visits. Wearable devices equipped with photoplethysmography (PPG), single-lead electrocardiography (ECG), and a...
D.Srinivasa Rao· Natural Resources for Human...· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduOct 13, 2026
Machine-learning networks can learn without detailed instructions from a designer. Those that do may offer insight into how the brain reorganizes itself during learning.
With $2.1 million funding from Google.org, the open-source Public Transit Intelligence Hub will unify public transit monitoring, operations, and passenger communication.